Partnership Opportunities
A Unique Opportunity to Learn Directly from Industry Pioneers
The 2025 inaugural Dark Genome Target Discovery & Development Summit, united the fast-growing industry pioneers mining non-coding DNA, RNA and proteins, providing the opportunity to learn and gain insight from those navigating this complex and highly unknown area.
Senior experts at ROME Therapeutics, Enara Bio, HAYA Therapeutics, HERVolution, CAMP4 Therapeutics, Immatics spotlighted cutting-edge research needed to drive novel target discovery, equip robust validation, and facilitate drug development.
With 6+ hours of dedicated networking available, attendees engaged in meaningful conversations, to learn how you could support this community drive novel target discovery, equip robust validation, and facilitate drug development. As a field still in its infancy, reach out to discuss how you can play your part in unlocking the potential of the dark genome in the future.
2025 Partners
Industry Leaders Need Your Solutions in
Next Gen Sequencing (NGS)
Whole Genome Sequencing
Genomics
Proteomics
Bioinformatics
Multiomics
Data
Libraries
More!
Who Did We Learn From in 2025?
Leading decision makers across discovery, biology, -omics, data science, computational biology, bioinformatics, and AI, provided a complete overview of the challenges, opportunities and priorities of this field.
